Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Corsica Health vs Liberty

Corsica Health
Graded #193

Higher grade

vs+5.299999999999997
Liberty
Graded #304

Lower grade

The verdict

Corsica Health takes it — 66.3/100 to 61/100.

Corsica Health grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Corsica Health is a telehealth platform offering both compounded GLP-1s and brand-name FDA-approved injections through a structured assessment, provider review, and medication flow.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueCorsica Health +4
48
44
Dose & formulationEven
77
77
Clinical oversightCorsica Health +11
87
76
Labs & monitoringEven
54
54
FulfillmentLiberty +6
75
81
Contract termsCorsica Health +35
55
20
Corsica Health · left barLiberty · right bar

The numbers

MetricCorsica HealthLiberty
WeighScore66.3/10061/100
GradeCC
Scorecard rank#193#304
Semaglutide$249/mo (compounded)$199/mo (compounded)
Tirzepatide$349/mo (compounded)$299/mo (compounded)
CoverageCoverage not publishedCoverage not published
Brand-name accessYesYes
Oral / sublingualInjection onlyInjection only
Corsica Health

Graded #193 · C

Strengths

  • Public pricing shown for both compounded and brand-name options — a real transparency advantage
  • $1,499/mo brand-name Wegovy/Ozempic/Mounjaro is below typical retail cash-pay
  • LegitScript Certified
  • Clear 3-step intake: Assessment, Provider Review, Receive Medication
  • $199/mo compounded semaglutide and $249/mo compounded tirzepatide (3-month plans) are competitively priced

Where it loses points

  • Legal entity name and state of incorporation not disclosed on the site
  • Pharmacy partner described only as a 'licensed compounding pharmacy,' not named
  • Per-state availability not listed publicly
  • First-month promotional pricing not disclosed
  • Lab-work inclusion not clearly disclosed
Liberty

Graded #304 · C

Strengths

  • Compounded GLP-1 sourced from FDA-registered 503B outsourcing facilities, a stricter standard than the 503A pharmacies many competitors use
  • Transparent flat pricing: compounded semaglutide $199/mo (about $171/mo on a 3-month supply) and tirzepatide $299/mo
  • Nationwide in all 50 states with free discreet shipping, 24/7 support, and FSA/HSA acceptance
  • Multi-vertical menu beyond weight loss (low-dose microdosing, NAD+, sermorelin, metformin) for patients who want bundled wellness care

Where it loses points

  • Does not name its specific compounding pharmacy partner, only that it is a 503B facility
  • Tirzepatide at $299/mo is mid-market rather than the cheapest option among compounded providers
  • Generic corporate branding (Liberty Health) with limited public detail on the operating entity
  • Compounded medication only — no brand-name or insurance-covered GLP-1 path

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard